Is there a time limit for systemic menopausal hormone therapy?

被引：5

作者：

Lipold, Laura Dorr ^{[1
]}

机构：

[1] Cleveland Clin, Beachwood Family Hlth Ctr, BD10,26900 Cedar Rd, Beachwood, OH 44122 USA

来源：

CLEVELAND CLINIC JOURNAL OF MEDICINE | 2016年 / 83卷 / 08期

关键词：

POSTMENOPAUSAL WOMEN; SOCIETY RECOMMENDATIONS; VENOUS THROMBOEMBOLISM; REPLACEMENT THERAPY; BREAST-CANCER; RISK; HEALTH; DISEASE; MANAGEMENT; VASOMOTOR;

D O I：

10.3949/ccjm.83a.15161

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In deciding whether it is time to stop hormone therapy, in addition to the patient's age we need to consider her preferences, symptoms, quality of life, time since menopause, hysterectomy status, and personal risks of osteoporosis, breast cancer, heart disease, stroke, and venous thromboembolism. This article presents the evidence for and against extending hormone therapy and a guide for making this highly individualized and shared decision.

引用

页码：605 / 612

页数：8

共 30 条

[1]

American College of Obstetricians and Gynecologists, 2014, Obstet Gynecol, V123, P202, DOI DOI 10.1097/01.AOG.0000441353.20693.78

[2]

[Anonymous], 2015, MENOPAUSE, V22, P693, DOI 10.1097/GME.0000000000000492

[3] The 2012 Hormone Therapy Position Statement of The North American Menopause Society [J].

不详 .

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2012, 19 (03) :257-271

[4] Duration of Menopausal Vasomotor Symptoms Over the Menopause Transition [J].

Avis, Nancy E. ;

Crawford, Sybil L. ;

Greendale, Gail ;

Bromberger, Joyce T. ;

Everson-Rose, Susan A. ;

Gold, Ellen B. ;

Hess, Rachel ;

Joffe, Hadine ;

Kravitz, Howard M. ;

Tepper, Ping G. ;

Thurston, Rebecca C. .

JAMA INTERNAL MEDICINE, 2015, 175 (04) :531-539

[5] Hormone therapy for preventing cardiovascular disease in post-menopausal women [J].

Boardman, Henry M. P. ;

Hartley, Louise ;

Eisinga, Anne ;

Main, Caroline ;

Roque i Figuls, Marta ;

Bonfill Cosp, Xavier ;

Gabriel Sanchez, Rafael ;

Knight, Beatrice .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (03)

[6] Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis [J].

Canonico, Marianne ;

Plu-Bureau, Genevieve ;

Lowe, Gordon D. O. ;

Scarabin, Pierre-Yves .

BMJ-BRITISH MEDICAL JOURNAL, 2008, 336 (7655) :1227-+

[7] Hormone therapy and venous thromboembolism among postmenopausal women -: Impact of the route of estrogen administration and progestogens:: The ESTHER study [J].

Canonico, Marianne ;

Oger, Emmanuel ;

Plu-Bureau, Genevieve ;

Conard, Jacqueline ;

Meyer, Guy ;

Levesque, Herve ;

Trillot, Nathalie ;

Barrellier, Marie-Therese ;

Wahl, Denis ;

Emmerich, Joseph ;

Scarabin, Pierre-Yves .

CIRCULATION, 2007, 115 (07) :840-845

[8] Effects of estrogen plus progestin on risk of fracture and bone mineral density - The Women's Health Initiative randomized trial [J].

Cauley, JA ;

Robbins, J ;

Chen, Z ;

Cummings, SR ;

Jackson, RD ;

LaCroix, AZ ;

LeBoff, M ;

Lewis, CE ;

McGowan, J ;

Neuner, J ;

Pettinger, M ;

Stefanick, ML ;

Wactawski-Wende, J ;

Watts, NB .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (13) :1729-1738

[9] Moderate Alcohol Consumption During Adult Life, Drinking Patterns, and Breast Cancer Risk [J].

Chen, Wendy Y. ;

Rosner, Bernard ;

Hankinson, Susan E. ;

Colditz, Graham A. ;

Willett, Walter C. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (17) :1884-1890

[10] Unopposed estrogen therapy and the risk of invasive breast cancer [J].

Chen, WY ;

Manson, JE ;

Hankinson, SE ;

Rosner, B ;

Holmes, MD ;

Willett, WC ;

Colditz, GA .

ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (09) :1027-1032

← 1 2 3 →